PPM1D exerts its oncogenic properties in human pancreatic cancer through multiple mechanisms

Bo Wu1, Bo-Min Guo2, Jie Kang2

  • 1Department of General Surgery, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, 600 YiShan Road, Shanghai, Shanghai, 200233, China. wubo7421@sohu.com.

Insights

Protein phosphatase, Mg(2+)/Mn(2+) dependent, 1D (PPM1D) acts as an oncogene in pancreatic cancer (PC). Overexpression of PPM1D promotes PC cell migration, invasion, and tumor growth while suppressing apoptosis, highlighting its clinical significance.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Protein phosphatase, Mg(2+)/Mn(2+) dependent, 1D (PPM1D) is recognized for its role in tumor suppression pathways.
  • The clinical significance of PPM1D in pancreatic cancer (PC) remains underexplored.

Purpose of the Study:

  • To investigate PPM1D expression in PC tissues and cell lines.
  • To elucidate the functional role of PPM1D in PC cell migration, invasion, and apoptosis.
  • To explore the underlying signaling pathways and in vivo tumorigenesis.

Main Methods:

  • Quantitative analysis of PPM1D expression in human PC tissues and cell lines.
  • In vitro assays assessing cell migration, invasion, and apoptosis.
  • Western blotting and signaling pathway analysis (Wnt/β-catenin, p38 MAPK/p53).
  • In vivo tumor growth studies in a mouse model.

Main Results:

  • PPM1D is significantly overexpressed in PC tissues and cell lines, correlating with tumor growth and metastasis.
  • PPM1D promotes PC cell migration and invasion by activating the Wnt/β-catenin pathway and downregulating apoptosis-stimulating of p53 protein 2 (ASPP2).
  • PPM1D suppresses PC cell apoptosis by inhibiting the p38 MAPK/p53 pathway and downregulating ASPP2.
  • ASPP2 is downregulated in PC tissues.
  • PPM1D enhances PC tumor growth in vivo.

Conclusions:

  • PPM1D functions as an oncogene in pancreatic cancer.
  • PPM1D overexpression drives PC progression through modulation of key signaling pathways and tumor suppressor proteins.
  • Targeting PPM1D may offer a therapeutic strategy for pancreatic cancer.